|
 |
![]()
|
< back /
08:30 |
Introduction |
|
|
08:35
 |
Incretin Hormones: Relevance to clinical management of diabetes |
David Thompson, MD |
08:55
|
Advances in Oral Therapy |
Greg Bondy, MD |
09:15
|
Insulin Delivery - Can we do better? |
Lawrence Leiter, MD |
09:35
|
Importance of Reaching an LDL Goal |
Greg Bondy, MD |
09:55 |
Q and A and Panel Discussion |
All faculty |
10:25 |
BREAK |
|
|
10:45
|
Update on Glycemic Control: Care gap |
John Mancini, MD |
11:10
|
Can We Stop the Progression of Diabetes: DREAM |
Greg Bondy, MD |
11:35
|
ADOPT: Are all hypoglycemic agents the same? |
Keith Dawson, MD |
12:00 |
Q and A and Panel Discussion |
|
12:30 |
LUNCH |
|
|
13:15
|
Cardiovascular Risk Stratification in the Patient With Type 2 Diabetes |
David Fitchett, MD |
13:35
|
Comprehensive Approach to Metabolic Improvement |
Lawrence Leiter, MD |
13:55
|
New Initiatives from the Canadian Heart Research Centre |
Anatoly Langer, MD |
14:15 |
Which Patients With Diabetes Should Have a Stress Test? Does it make a difference? |
David Fitchett, MD |
14:35 |
Q and A and Panel Discussion |
All faculty |
15:00 |
CLOSE |
|
|
|
 |
|
